Lobbying disclosures · Lobbying report
SOLV: second_quarter 2026 lobbying report
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development. Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Follow SOLV- Became public
- Jul 18, 2026, 2:26 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 3:49 AM EST
Why this is connected
Legal-name match: SOLVENTUM CORPORATION is Solventum Corp (https://www.sec.gov/Archives/edgar/data/1964738/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/3ef76f40-e348-4049-aeff-24437a0cad95/","filing_uuid":"3ef76f40-e348-4049-aeff-24437a0cad95","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3ef76f40-e348-4049-aeff-24437a0cad95/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jonathon Jones, Partner","dt_posted":"2026-07-18T14:26:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"750 9th Street NW","registrant_address_2":"Suite 501","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":20744,"url":"https://lda.gov/api/v1/registrants/20744/","house_registrant_id":31587,"name":"TIBER CREEK GROUP","description":"Government Relations.","address_1":"750 9th Street NW","address_2":"Suite 501","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GRACE BAUM","contact_telephone":"+1 202-381-6896","dt_updated":"2026-07-20T13:07:00.819992-04:00"},"client":{"id":65777,"url":"https://lda.gov/api/v1/clients/65777/","client_id":65777,"name":"SOLVENTUM CORPORATION","general_description":"Healthcare Company.","client_government_entity":null,"client_self_select":false,"state":"MN","state_display":"Minnesota","country":"US","country_display":"United States of America","ppb_state":"MN","ppb_state_display":"Minnesota","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-03-11"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107185,"prefix":null,"prefix_display":null,"first_name":"COREY","nickname":null,"middle_name":null,"last_name":"MALMGREN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107259,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"KIRKLAND","last_name":"TWOMEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143334,"prefix":"mr","prefix_display":"MR.","first_name":"DANIEL","nickname":null,"middle_name":"HOWARD","last_name":"ZAWITOSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":53494,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"MCKECHNIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67494,"prefix":null,"prefix_display":null,"first_name":"KRISTEN","nickname":null,"middle_name":null,"last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67494,"prefix":null,"prefix_display":null,"first_name":"KRISTEN","nickname":null,"middle_name":null,"last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107185,"prefix":null,"prefix_display":null,"first_name":"COREY","nickname":null,"middle_name":null,"last_name":"MALMGREN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107259,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"KIRKLAND","last_name":"TWOMEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143334,"prefix":"mr","prefix_display":"MR.","first_name":"DANIEL","nickname":null,"middle_name":"HOWARD","last_name":"ZAWITOSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":53494,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"MCKECHNIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in SOLV
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jan 23, 2026$15K–$50K
Rep. J. French Hill (R-AR-2)
$15K–$50K · Traded Dec 31, 2025 · disclosed Jan 23, 2026
- Feb 21, 2025$1K–$15K
Sen. Ron Wyden (D-OR)
$1K–$15K · Traded Feb 6, 2025 · disclosed Feb 21, 2025 · Spouse
- Feb 12, 2025$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Jan 15, 2025 · disclosed Feb 12, 2025 · Joint
- Aug 16, 2024$1K–$15K
Rep. Charles J. "Chuck" Fleischmann (R-TN-3)
$1K–$15K · Traded Jul 8, 2024 · disclosed Aug 16, 2024 · Joint
- Jun 14, 2024$1K–$15K
Sen. Tommy Tuberville (R-AL)
$1K–$15K · Traded May 3, 2024 · disclosed Jun 14, 2024 · Joint
- May 23, 2024$1K–$15K
Sen. Gary C. Peters (D-MI)
$1K–$15K · Traded May 14, 2024 · disclosed May 23, 2024
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.